Ngaphandle kokuba ukudla kwakho kutholakale ne-calcium, i-calcium ne-vitamin D isilwane kunconywa ukuthola inzuzo enkulu ku-Evista (Raloxifene).
Ngokusho kwe-National Osteoporosis Foundation, abantu abadala abangama-50 nangaphezulu badinga i-1,200 mg ye-calcium no-800 kuya ku-1 000 i-vitamin D3 nsuku zonke. Umthombo okhethekayo we-calcium ukudla okucebile nge-calcium, njengemikhiqizo yobisi, tofu, imifino ethile eluhlaza nokudla okuqinisekisiwe nge- calcium .
Yini i-Evista?
I-Evista uhlobo lomuthi wokudokotela obizwa ngokuthi i-selective estrogen receptor modulator (SERM). Isetshenziselwa ukuphatha noma ukuvimbela i-osteoporosis kwabesifazane emva kokuya esikhathini.
Uma usuqeda ukuphuma esikhathini, umzimba wakho ukhiqiza i-estrogen encane, okungathi, kwabanye besifazane, ingenza amathambo athole amandla futhi athakathaka. U-Evista usebenza ngokusiza ukwenza amathambo akho anamandla futhi angeke aphule. Kuyasiza ekuvimbeleni i-osteoporosis ngokwakha ithambo nokuvimba ukucwiliswa kwamathambo okungenzeka ngemva kokumisa esikhathini.
Ingabe i-Evista ivimbela umdlavuza webele?
Ngokusho kwe-US Food and Drug Administration (FDA), uma une-osteoporosis noma usengozini enkulu yomdlavuza webele, u-Evista angasetshenziswa ukunciphisa amathuba akho okuthola umdlavuza webele we-invasive .
Nakuba u-Evista angeke aqede ngokuphelele ingozi yokuthola umdlavuza webele, udokotela wakho angalinganisa amathuba akho ngokuthola izinto zakho ezingozini, kuhlanganise neminyaka yakho, umlando womndeni wesifo somdlavuza webele (kumama wakho, udadewabo noma indodakazi), futhi umlando wanoma yisiphi isifuba sebele , ikakhulukazi i-biopsy engavamile.
Wena nodokotela wakho ungabe usuqaphela ukuthi izinzuzo zokuthatha u-Evista zingaphezu kwezingozi zomuthi.
Yiziphi Izingozi Zokubheka?
Kwabesifazane abathile, imiphumela emibi kakhulu ingenzeka ngenkathi ithatha u-Evista, kufaka phakathi i-blood clots ne-stroke.
Ingozi eyengeziwe yokweqa igazi emilenzeni (i-vein thrombosis ejulile) kanye namaphaphu (embolism embolism) ibike nge-Evista.
Uma unayo noma uke wafaka ama-blood clots emilenzeni yakho noma kumaphaphu, akufanele uthathe u-Evista. Ukuhlala isikhathi eside (njengokuhlala phansi emotweni ende noma ukuhamba ngezindiza, noma ukulala embhedeni ngemva kokuhlinzwa) kungandisa ingozi yezindwangu zegazi.
Uma uye waba nesifo senhliziyo noma usesengozini yokuhlaselwa yinhliziyo, ungase ube nengozi eyengeziwe yokufa ngesifo uma uthatha u-Evista.
Uma okwamanje uthatha i-Evista, yeka ukuthatha bese ushayele udokotela wakho uma unayo:
- ubuhlungu bomlenze noma umuzwa wokufudumala emlenzeni wakho ophansi (ithole)
- ukuvuvukala kwemilenze, izandla, noma izinyawo
- ubuhlungu besifuba, ukuphefumula, noma igazi lapho ukhwehlela
- ushintsho okungazelelwe embonweni wakho, njengokulahlekelwa kombono noma umbono obonakalayo
Ngingayitholaphi Ulwazi Olwengeziwe Nge-Evista?
Ukuze ufunde kabanzi mayelana ne-Evista, funda umhlahlandlela wemithi ye-Evista okufanele unikezwe uma ugcwalisa imithi yakho yokuqala kanye nesikhathi ngasinye lapho uthola khona ukuvuselelwa. Uma ungatholi umhlahlandlela wemithi, cela umuthi wakho wezokwelapha ukuthi ashicilele eyodwa. Ungathola futhi umhlahlandlela ku-intanethi kuwebhusayithi ye-Eli Lilly neNkampani ( PDF ).
Ngaphandle kwezixwayiso mayelana ne-Evista evela ku-FDA, umhlahlandlela wezokwelapha ukwazisa ngemiphumela emibi kanye nokusebenzisana kwezidakamizwa.
Uma unemibuzo mayelana nokusebenzisa i-Evista, khuluma nodokotela wakho.
Ukwaziswa Olwengeziwe Nge-Osteoporosis:
- I-National Osteoporosis Foundation (NOF) - i-website ye-NOF inikeza ulwazi oluhle kubathengi mayelana nokuvimbela nokwelashwa kwe-osteoporosis, kufaka phakathi amathiphu okuphepha mayelana nendlela yokuvimbela ama-fractures.
- I-ostoporosis - umbiko ojulile, odwetshiwe mayelana nokuqeda i-osteoporosis evela kwi-Health Encyclopedia.
Imithombo:
I-FDA ivumela ukusetshenziswa okusha kwe-Evista. I-FDA News Release. Ukuphathwa kwe-US nokuDrug. http://www.fda.gov/cder/Offices/OODP/whatsnew/raloxifene.htm
I-Evista: Amaphuzu avelele ekuchazeni ulwazi. I-label ye-FDA yeDrand yaseMthethweni. Ukuphathwa kwe-US nokuDrug. http://www.fda.gov/cder/foi/label/2007/022042lbl.pdf